Research location

Smolensk

Russia

Published trials254

Site observations267

Linked trials published254

Page2 / 6

Research activity in Smolensk

Russia

CureCurrent currently publishes aggregate city-level research activity for this location: 254 trials and 267 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Smolensk

254 linked trials · page 2 of 6

A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350NCT02983227 · 2016-11-30 · 1 site observation

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)NCT02970305 · 2016-11-04 · 1 site observation

Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected AdultsNCT02951052 · 2016-10-28 · 1 site observation

ACTIVE_NOT_RECRUITING

Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive ParticipantsNCT02938520 · 2016-10-27 · 1 site observation

ACTIVE_NOT_RECRUITING

Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)NCT02970292 · 2016-10-26 · 1 site observation

XC8 in the Treatment of Patients With Bronchial AsthmaNCT03450434 · 2016-09-20 · 1 site observation

Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)NCT02833350 · 2016-09-09 · 1 site observation

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid ArthritisNCT02831855 · 2016-09-01 · 1 site observation

A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease DementiaNCT02783573 · 2016-07-01 · 1 site observation

A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 AgonistNCT02808819 · 2016-06-30 · 1 site observation

Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPDNCT02766608 · 2016-05-31 · 2 site observations

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes MellitusNCT02735044 · 2016-04-14 · 1 site observation

TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)NCT02676089 · 2016-04-06 · 1 site observation

A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With AsthmaNCT02554786 · 2015-12-29 · 2 site observations

Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With AsthmaNCT02571777 · 2015-12-08 · 3 site observations

A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic AsthmaNCT02596321 · 2015-10-01 · 1 site observation

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 DiabetesNCT02461589 · 2015-09-21 · 1 site observation

A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin AloneNCT02419612 · 2015-08-14 · 1 site observation

A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected SubjectsNCT02431247 · 2015-07-06 · 1 site observation

A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPDNCT02371629 · 2015-06-24 · 1 site observation

A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis PatientsNCT02405780 · 2015-06-10 · 1 site observation

Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple SclerosisNCT02425644 · 2015-06-04 · 1 site observation

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)NCT02429791 · 2015-04-14 · 1 site observation

Observational Multicenter Non-interventional Study on COPD Patients Treatment Strategies at the Time of Hospital Discharge and Within 12 Months of Follow-up on an Outpatient Primary Care BasementNCT02346292 · 2015-03-31 · 1 site observation

Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid ArthritisNCT02638259 · 2015-02-21 · 1 site observation

Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line TreatmentNCT02227238 · 2014-12-11 · 1 site observation

Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)NCT02294058 · 2014-12-03 · 1 site observation

A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis PatientsNCT02260791 · 2014-12-01 · 1 site observation

A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABANCT02258542 · 2014-11-19 · 1 site observation

Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection FractionNCT02226120 · 2014-10-16 · 1 site observation

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With MethotrexateNCT02187055 · 2014-08-01 · 1 site observation

Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection FractionNCT01920711 · 2014-07-18 · 1 site observation

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryNCT02138916 · 2014-06-13 · 1 site observation

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)NCT02115750 · 2014-05-01 · 1 site observation

Study of SPARC1103 in Subjects With SpasticityNCT02027025 · 2014-04-21 · 1 site observation

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung CancerNCT02106546 · 2014-04-10 · 1 site observation

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid ArthritisNCT02092467 · 2014-03-14 · 1 site observation

Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD RegimenNCT01985334 · 2014-02-14 · 1 site observation

A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes MellitusNCT01989754 · 2014-01-16 · 1 site observation

A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsNCT02111564 · 2014-01-07 · 1 site observation

Efficacy and Safety Study of Ozanimod in Relapsing Multiple SclerosisNCT02047734 · 2013-12-03 · 2 site observations

Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 DiabetesNCT01930188 · 2013-12-02 · 1 site observation

A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Fluticasone Propionate/Salmeterol (FSC) 250/50 Microgram (mcg) Through a Capsule-Based Inhaler and a Multi-Dose Inhaler Administered Twice Daily (BID) in Adults With Chronic Obstructive Pulmonary Disease (COPD)NCT01978145 · 2013-11-14 · 1 site observation

A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol (FSC) 250/50 Microgram (mcg) Twice Daily (BID) in Adults and Adolescents With AsthmaNCT01978119 · 2013-11-06 · 1 site observation

Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid ArthritisNCT01999192 · 2013-10-01 · 1 site observation

Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled AsthmaNCT01928771 · 2013-09-19 · 1 site observation

A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)NCT01910402 · 2013-08-22 · 1 site observation

Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003NCT01856309 · 2013-08-07 · 1 site observation

A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller MedicationNCT01867125 · 2013-07-25 · 1 site observation

A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01879410 · 2013-06-13 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.